VSP-17, a New PPARγ Agonist, Suppresses the Metastasis of Triple-Negative Breast Cancer via Upregulating the Expression of E-Cadherin

VSP-17, a New PPARγ Agonist, Suppresses the Metastasis of Triple-Negative Breast Cancer via Upregulating the Expression of E-Cadherin

Triple-negative breast cancer (TNBC), an aggressive subtype of breast cancer, shows higher metastases and relapse rates than other subtypes. The metastasis of TNBC is the main reason for the death of TNBC patients. Increasing evidence has shown that inhibiting the metastasis of TNBC is a good method...

Full description

Bibliographic Details
Main Authors: Yuhui Wang, Menglin Zhu, Bo Yuan, Kefeng Zhang, Mingli Zhong, Wei Yi, Xiaotian Xu, Xiaoqun Duan
Format: Article
Language:English
Published: MDPI AG 2018-01-01
Series:Molecules
Subjects:
VSP-17
triple-negative breast cancer
metastasis
E-cadherin
PPARγ
agonist
Online Access:http://www.mdpi.com/1420-3049/23/1/121

Internet

http://www.mdpi.com/1420-3049/23/1/121

Similar Items